Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Both mouse and rat models are effective for testing alopecia areata treatments.

IL-27 can prevent hair loss in alopecia areata.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Animal and mathematical models help understand and develop treatments for alopecia areata.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Squaric acid dibutylester helps hair growth by increasing certain immune cells in the skin.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

ILC1-like cells can independently cause alopecia areata.

The excimer laser may help hair regrow in alopecia areata patients.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Alopecia areata in these mice is inherited, more common in young females, and can be treated with triamcinolone acetonide.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

ILC1 cells contribute to hair loss in alopecia areata.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

IL-27 may help prevent hair loss by creating immune-suppressing cells.